U of T Aredia

U of T Libraries U of T Home Portal ROSI Campus Maps
University of TorontoTSpace
First time users
TSpace Repository University of Toronto Scarborough Bioline International Legacy Collection Bioline International Legacy Collection
Pamidronate – a promising new candidate for the management of spondyloarthropathy
S.M. Akerkar; L.S. Bichile
Issue Date:
Medknow Publications on behalf of Indian Journal of Medical Sciences Trust
Indian Journal of Medical Sciences (ISSN: 0019-5359) Vol 59 Num 4
Abstract (summary):
Bisphosphonate group of agents are known for their anti-bone resorptive properties. However, recently their anti-inflammatory and anti-arthritis properties have come to light. Clinical trials of their use in spondyloarthropathy are showing promising results, especially in patients with shorter disease duration. The adverse event profile is mainly limited to postinfusion arthralgia, myalgia and fever. The concept of pamidronate in spondyloarthropathy management should be evaluated further in light of these clinical studies and could have a major impact on our resource-restricted setting.


About garyskeete

ASHWORTH MEDICINE-Professional Medical Assisting, Doctor of Science,Legal Assistant Diploma BSc Criminal Justice PhD Computational Neuroscience MD DSC Epigenetics
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s